Kurt Calia is a partner in our Silicon Valley office practicing in the areas of complex civil litigation, patent litigation, intellectual property, life sciences, and patent prosecution. He is a former co-chair of the firm's Patent Group, and he currently serves as the Vice Chair for the Trade Secrets Committee of the Intellectual Property Owner’s Association (IPO).
Mr. Calia's practice focuses largely on the firm's high technology clients in a wide range of areas including pharmaceutical chemistry, agricultural biotechnology, biomedical devices, nanotechnology, genetics, mechanical devices, business methods, microprocessors, and software.
Mr. Calia has significant trial experience, having recently appeared as patent trial counsel in the International Trade Commission for Samsung related to light-emitting diodes, for a J&J subsidiary concerning an Alzheimer’s disease drug, and having previously participated in several intellectual property trials for Monsanto concerning genetically modified crops.
Mr. Calia also has substantial experience in prosecuting and defending trade secrets cases, particularly arising in the context of complex litigation involving other intellectual property claims.
Mr. Calia has also published and lectured on intellectual property issues, and previously served as an Adjunct Professor at the Howard University Law School where he taught a course on patent enforcement.
- Ali v. Carnegie Institution of Washington and University of Massachusetts (D. Ore. 2012) – inventorship dispute related to intellectual property rights to RNA interference.
- Swanson v. ALZA Corp. (N.D. Cal. 2012) – inventorship dispute related to intellectual property rights to the ADHD drug, Concerta©.
- In re: Certain Light Emitting Devices, 337-TA-785 (ITC, 2011) – patent infringement matter related to light-emitting diodes.
- Representation of Pharmaceutical Research & Manufacturers Association (PhRMA) as an amicus in Federal Circuit and Supreme Court appeals in Ass’n for Molecular Pathology et al. v. United States Patent & Trademark Office (Fed. Cir. 2010, 2012) – patent appeal related to the patent-eligibility of DNA sequences and methods of screening cancer therapeutics.
- Monsanto Company et al. v. E.I. DuPont De Nemours & Co. et al. (E.D. Mo. 2009) - patent, contract, and antitrust litigation related to genetically modified crops.
- Janssen L.P. et al. v. Barr Laboratories et al. (D.N.J. 2007), Janssen L.P. et al. v. KV Pharmaceuticals, Inc. (D.N.J. 2007), Janssen L.P. et al. v. Barr Laboratories, Inc., et al. (D.N.J. 2006), and Janssen L.P. et al. v. Sandoz, Inc. (D.N.J. 2006) - patent infringement actions related to Alzheimer’s disease drug, Razadyne®-ER.
- Blackbird Technologies, Inc. v. Applied Security, Inc. et al. (Fairfax County Cir. Ct. 2007) - employee agreement contract dispute.
- In re: ‘318 Patent Infringement Litigation (D. Del. 2005) - patent infringement case involving Alzheimer’s disease drug, Razadyne®.
Honors and Rankings
- IAM Patent 1000 - The World’s Leading Patent Practitioners (2012-2013)
- Recognized by Legal 500 US in Litigation: Trade Secrets (2009-2014) and Intellectual Property - Patent Prosecution (2013)
- Northern California Super Lawyers, Intellectual Property (2013)
- Representation of the American College of Obstetricians and Gynecologists in constitutional challenges to the Partial Birth Abortion Ban Act of 2003 (U.S. Supreme Court) and Michigan Legal Birth Definition Act (6th Cir.).
- Representation of the Religious Coalition for Reproductive Choice in constitutional challenge to New Hampshire parental notification law (U.S. Supreme Court).
- Representation of the Welfare Rights Organizing Coalition in administrative litigation opposing proposed conversion of healthcare organization from non-profit to for-profit status in Washington State and Alaska.
- Representation of the California Medical Association, Association of Reproductive Health Professionals, Physicians for Reproductive Choice and Health, and individual physicians in constitutional challenges to the Partial Birth Abortion Ban Act of 2003 (N.D. Cal., 2nd Cir., 8th Cir., and 9th Cir.).
- Representation of Alabama death row inmate in post-conviction proceedings.
- Representation of D.C. Appleseed in litigation legislation related to healthcare insurance reform.
- Representation of a death row inmate at San Quentin in an excessive use of force and equal protection claim.
- Representation of Sudanese lawyer in political asylum application.
- Gray v. Poole et al. (D.D.C. 1999) (D.C. Cir. 2000) - representation of corporation counsel lawyer in defending prior prosecution of child neglect action.
- Center to Prevent Handgun Violence v. U.S. Dept. of Treasury et al., (D.D.C. 1996) - FOIA litigation related to multiple handgun sales records.
- Representation of D.C. Jail inmate in a murder trial.
Memberships and Affiliations
- Mr. Calia currently serves as the Vice Chair of the Trade Secrets Committee of the Intellectual Property Owners Association (IPO).
Publications and Speeches
- "Patent Practice & Enforcement", Howard University Law School (Aug.-Dec. 2009)
- "e-Discovery," IP Global Conference, Austin, Texas (Feb. 2009)
- "Privilege and Privacy," General Counsel Conference, Washington, DC (Oct. 2008)
- "Settlement Agreements," IP Global Conference, Pinehurst, NC (May 2008)
- International Judicial Academy Colloquium on Intellectual Property and Scientific Evidence, Delegation member/faculty, (Argentina, Aug.-Sept. 2007)
- "Gene Patents," University of Maryland School of Law Seminar (March 2007)
- "The Role of Patent Lawyers, both Generally and in the Context of Markman Hearings," Conducting Markman Hearings in Patent Infringement Lawsuits: Leading Lawyers on Interpreting Claims, Developing Court Presentations, and Making a Strong Argument (Inside the Minds) (February 2007)
- ALI-ABA's "Trial of a Patent Case," Faculty member (Chicago, Sept. 2005)